Summary
The significance of interleukin-6 (IL-6) in patients with inflammatory bowel disease (IBD) was studied by measuring the IL-6 level in serum and colonic tissue by means of an enzyme-linked immunosorbent assay (ELISA), and by examining its localization using an immunohistochemical method. The serum IL-6 level reflected the degree of disease activity, and the extent of affected area, and was also correlated with the serum C-reactive protein (CRP) level. In the colonic mucosa of active IBD, the tissue IL-6 level was markedly elevated, and immunoreactive products of anti-IL-6 antibody were present in infiltrative mononuclear cells in the lamina propria. This indicates that IL-6 production in these cells is enhanced at the site of affected intestine. These results, together with its biological activity and the type of cell producing it, suggest that IL-6 is an available marker to assess disease conditions of IBD and that it might be also involved in the pathophysiology of IBD.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kishimoto T: The biology of interleukin 6. Blood 1989;74:1–10
Le JM, Vilcek J: Interleukin 6. A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989;61:588–602
Horii Y, Muraguchi A, Suematsu S, et al: Regulation of BSF-2/ IL-6 production by human mononuclear cells. J Immunol 1988;141:1529–1535
Andus T, Geiger T, Hirano T, et al: Recombinant human B cell stimulatory factor 2(BSF-2/IFN-β 2) regulatesβ-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett 1987;221:18–22
Castell JV, Gomez-Lechon Mj, David M, et al: Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulated the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988;232:347–350
Geiger T, Andus T. Klapproth J, et al: Induction for rat acutephase proteins by interleukin-6 in vivo. Eur J Immunol 1988;18: 717–721
Muraguchi A, Hirano T, Tang B, et al: The essential role of B-cell stimulatory factor 2(BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Mcd 1988;167:332–344
Takatsuki F, Okano A, Suzuki C, et al: Human recombinant interleukin 6/B cell stimulatory factor 2(IL-6/BSF-2) augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 1988; 141:3072–3077
Lotz M, Jirik F. Kabouridis R, et al: BSF-2/IL-6 is costimulant for human thymocytes and T lymphocytes. J Exp Med 1988;167: 1253–1258
Helle M, Brakenhoff JPJ. De Groot ER, et al: Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 1988;18:957–959
Uyttenhove C, Coulie PG, Van Snick J: Tcell growth and differentiation induced by interleukin-HP1/IL-6. the murine hybridoma/plasmacytoma growth factor. J Exp Med 1988;167:1417–1427
Le J, Fredrickson G, Reis LFL, et al: Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci USA 1988;85:8643–8647
Ceuppens JL, Baroja ML, Lorre K, et al: Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol 1988;141:3868–3874
Ishibashi T, Kimura H, Uchida T, et al: Human inteleukin 6 is a direct promoter of maturation of megakaryocytes in vitro: Proc Natl Acad Sci USA 1989;86:5953–5957
Ishibashi T, Kimura H, Shikawa Y, et al: Interleukin-6 is a potent thrombopietic factor in vivo in mice. Blood 1989;74:1241–1244
Hirano T, Taga T, Yasukawa K, et al: Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 1987;84:228–231
Yoshizaki K, Matsuda T, Nishimoto N, et al: Pathogenic significance of interleukin-6(IL-6/BSF-2) in Castleman’s disease. Blood 1989;74:1360–1367
Hirano T, Matsuda T, Turner M, et al: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988;18:1797–1801
Houssiau FA, Devogelaer JP, Damme JV, et al: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arth Rheum 1988;31:784–788
Horii Y, Muraguchi A, Iwano M, et al: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989;143:3949–3955
Ucno Y, Takano N, Kaneganc H, et al: The acute phase nature of interleukin 6. Studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989;76:337–342
Devierc J, Content J, Denys C, et al: High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA scrum levels and lymphokines production. Clin Exp Immunol 1989;77:221–225
MacDermott RP. Stenson WF: Inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Immunology and Immunopathology of the Liver and Gastrointestinal Tract, 1st Ed. Igaku-Shoin, New York, Tokyo. 1990;459–486
Brandtzaeg P, Halstensen TS, Kett K, et al: Immunobiology and immunopathology of human gut mucosa. Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97: 1562–1584
Truelovc SC, Witts LJ: Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Mcd J 1955;2:1041–1048
Myren J, Bouchier IAD, Watkinson G, et al: The OMGE multinational inflammatory bowel disease survey 1976–1982. A further report on 2657 cases. Scand J Gastroenterol 1984;19 (suppl.95):1–27
Breen EC, Rezai AR, Nakajima K, et al: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480–484
Miki S. Iwano M, Miki Y, et al: Interleukin-6(IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607–610
Rachmilewitz D, Simon PL, Schwartz L, et al: Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989;97:326–337
Kishimoto T, Hirano T: Molecular regulation of B lymphocyte response. Ann Rev Immunol 1988;6:485–512
Nishimoto N, Yoshizaki K, Tagoh H, et al: Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 1989;50: 399–401
Nijisten MWN. De Groot ER. Ten Duis HJ, et al: Serum levels of interleukin-6 and acute phase responses. Lancet 1987;2:921
Houssiau FA, Bukasa K, Sindic CJM, et al: Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 1988;71:320–323
Brandtzacg P, Baklien K, Fausa O, et al: Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis. Gastroenterology 1974;66:1123–1136
Frei K, Leist TP, Meager A, et al: Production of B cell stimulatory factor-2 and interferon y in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med 1988;168:449–453
Tovey MG, Content J, Gresser I, et al: Genes for IFN-β 2 (IL-6), tumor necrosis factor, and IL-1 arc expressed at high levels in organs of normal individuals. J Immunol 1988;141:3106–3110
Hirano T: Metabolism and Disease 1988;25(suppl.):135–143 (in japanese)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitsuyama, K., Sata, M. & Tanikawa, K. Significance of interleukin-6 in patients with inflammatory bowel disease. Gastroenterol Jpn 26, 20–28 (1991). https://doi.org/10.1007/BF02779504
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02779504